Anrukinzumab Antibody
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Its anti-inflammatory efficacy, validated in primate disease models, supports ongoing research for ulcerative colitis and asthma, including both in vivo and in vitro experimental applications.
Product Specifications
Product Name Alternative
IMA-638
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.15 mg/mL
Purity
97.00% (May vary between batches)
Molecular Weight
145.38 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0035711-01 20 µL
Monoclonal Antibody to Pancreatic Polypeptide (PP)
Sign In for Pricing
View Details TRV-0035711-02 100 µL
Monoclonal Antibody to Pancreatic Polypeptide (PP)
Sign In for Pricing
View Details TRV-0035711-03 200 µL
Monoclonal Antibody to Pancreatic Polypeptide (PP)
Sign In for Pricing
View Details TRV-0035711-04 1 mL
Monoclonal Antibody to Pancreatic Polypeptide (PP)
Sign In for Pricing
View Details 
MBS6400651-01 0.1 mL
GJB1 (Gap Junction beta-1 Protein, Connexin-32, Cx32, GAP Junction 28kD Liver Protein, CX32) (HRP)
Sign In for Pricing
View Details